Susceptibility of strains of Streptococcus agalactiae to macrolides and lincosamides, phenotype patterns and resistance genes
- 1 November 2002
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 8 (11) , 745-748
- https://doi.org/10.1046/j.1469-0691.2002.00450.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Mechanisms of Macrolide Resistance in Clinical Group B Streptococci Isolated in FranceAntimicrobial Agents and Chemotherapy, 2001
- Antibiotic Susceptibility Profiles for Group B Streptococci Isolated from Neonates, 1995-1998Clinical Infectious Diseases, 2000
- High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998Journal of Antimicrobial Chemotherapy, 2000
- Antimicrobial Susceptibility Patterns of Streptococcus agalactiae in a German University HospitalScandinavian Journal of Infectious Diseases, 2000
- Group B streptococcusThe Lancet, 1999
- Antimicrobial Susceptibilities of Group B Streptococci Isolated between 1992 and 1996 from Patients with Bacteremia or MeningitisAntimicrobial Agents and Chemotherapy, 1998
- Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococciAntimicrobial Agents and Chemotherapy, 1994
- Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in FinlandJournal of Antimicrobial Chemotherapy, 1993
- Antimicrobial Susceptibility of Group B Streptococci Isolated from a Variety of Clinical SourcesAntimicrobial Agents and Chemotherapy, 1976
- Susceptibility of Hemolytic Streptococci, Other Than Those of Group D, to Eleven AntibioticsIn VitroAmerican Journal of Clinical Pathology, 1957